Dr. Weiss on Enhancing Tumor Control With JNJ-1900
How Do Immune Checkpoint Inhibitors Affect Quality of Life in Real-World Patients With NSCLC?
Data on RNA-Based Cancer Vaccine Plus Cemiplimab for NSCLC Presented at AACR 2025
Surgery in Oligometastatic Disease: Dr. Antonoff Shares Insights
Phase 3 SKYSCRAPER-01 Study: Final PFS, OS Analyses Presented at AACR 2025
Beamion LUNG-1: Zongertinib Shows ‘Significant’ Activity in Patients With NSCLC Harboring HER2 Mutations